Cargando…

Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients

We report the cases of two young German male patients with treatment-resistant Tourette syndrome (TS), who suffer from incapacitating stuttering-like speech disfluencies caused by vocal blocking tics and palilalia. Case 1: a 19-year old patient received medical cannabis at a dose of 1 × 0.1 g cannab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakubovski, Ewgeni, Müller-Vahl, Kirsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578129/ https://www.ncbi.nlm.nih.gov/pubmed/28796166 http://dx.doi.org/10.3390/ijms18081739

Ejemplares similares

Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
por: Kanaan, Ahmad Seif, et al.
Publicado: (2017)

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome
por: Gerasch, Sarah, et al.
Publicado: (2016)

New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center
por: Sambrani, Tanvi, et al.
Publicado: (2016)

Non-just-right experiences are more closely related to OCD than tics in Tourette patients
por: Brandt, Valerie, et al.
Publicado: (2023)

Premonitory Urge and Tic Severity, Comorbidities, and Quality of Life in Chronic Tic Disorders
por: Brandt, Valerie, et al.
Publicado: (2023)

Tic disorders revisited: introduction of the term “tic spectrum disorders”
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2019)

Stop that! It’s not Tourette’s but a new type of mass sociogenic illness
por: Müller-Vahl, Kirsten R, et al.
Publicado: (2021)

Blocking Tics in Gilles de la Tourette Syndrome
por: Kaczyńska, Justyna, et al.
Publicado: (2021)

Reply: A call for caution: ‘stop that’ sentiments threaten tic research, healthcare and advocacy progress
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022)

Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study
por: Haas, Martina, et al.
Publicado: (2021)

Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders
por: Essing, Jana, et al.
Publicado: (2022)

The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders
por: Jakubovski, Ewgeni, et al.
Publicado: (2016)

The Rage Attack Questionnaire-Revised (RAQ-R): Assessing Rage Attacks in Adults With Tourette Syndrome
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2020)

Tonic Tics in Gilles de la Tourette Syndrome
por: Kaczyńska, Justyna, et al.
Publicado: (2021)

Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis
por: Szejko, Natalia, et al.
Publicado: (2020)

European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions
por: Andrén, Per, et al.
Publicado: (2021)

ONLINE-TICS: Internet-Delivered Behavioral Treatment for Patients with Chronic Tic Disorders
por: Haas, Martina, et al.
Publicado: (2022)

Cognitive flexibility and its electrophysiological correlates in Gilles de la Tourette syndrome
por: Lange, Florian, et al.
Publicado: (2017)

Cognitive Tic-Like Phenomena in Gilles de la Tourette Syndrome
por: Janik, Piotr, et al.
Publicado: (2021)

Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022)

Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2020)

Editorial: The Neurobiology and Genetics of Gilles de la Tourette Syndrome: New Avenues through Large-Scale Collaborative Projects
por: Paschou, Peristera, et al.
Publicado: (2017)

European clinical guidelines for Tourette syndrome and other tic disorders: summary statement
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2021)

Repetitive Behaviours in Patients with Gilles de la Tourette Syndrome: Tics, Compulsions, or Both?
por: Worbe, Yulia, et al.
Publicado: (2010)

Phenomenology and Clinical Correlates of Stimulus-Bound Tics in Gilles de la Tourette Syndrome
por: Janik, Piotr, et al.
Publicado: (2018)

Altered intrahemispheric structural connectivity in Gilles de la Tourette syndrome()()
por: Cheng, Bastian, et al.
Publicado: (2013)

Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2015)

Is Persistent Motor or Vocal Tic Disorder a Milder Form of Tourette Syndrome?
por: Claudio‐Campos, Karla, et al.
Publicado: (2021)

The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2023)

Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study
por: Baumgaertel, Charlotte, et al.
Publicado: (2019)

Prevalence and clinical correlates of misophonia symptoms in the general population of Germany
por: Jakubovski, Ewgeni, et al.
Publicado: (2022)

Tics and Tourette’s syndrome
por: Mittal, Shivam Om
Publicado: (2020)

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
por: Jakubovski, Ewgeni, et al.
Publicado: (2020)

Validation of the Rage Attack Questionnaire-Revised (RAQ-R) in a Mixed Psychiatric Population
por: Palm, Lisa, et al.
Publicado: (2021)

Toward a Multifactorial Conception of the Gilles de la Tourette Syndrome and Persistent Chronic Tic Disorder
por: Lavoie, Marc E., et al.
Publicado: (2017)

Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray
por: Schwittay, Maximilian A., et al.
Publicado: (2021)

Treatment of Tourette Syndrome with Cannabinoids
por: Müller-Vahl, Kirsten R.
Publicado: (2013)

Convergent imaging-transcriptomic evidence for disturbed iron homeostasis in Gilles de la Tourette syndrome
por: Kanaan, Ahmad Seif, et al.
Publicado: (2023)

Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
por: Anis, Saar, et al.
Publicado: (2022)

Childhood Predictors of Long-term Tic Severity and Tic Impairment in Tourette’s Disorder
por: Ricketts, Emily J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bn5tht55isqn6ptj8nmovdet8k